Vimarsana
Biggest News Aggregation in the World

Molecular Simulation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Simulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Simulation Today - Breaking & Trending Today

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD - Vimarsana News

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

/PRNewswire/ -- DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1....

Hagler Institute Announces Its Largest Class Of New Fellows: 14 - Vimarsana News

Hagler Institute Announces Its Largest Class Of New Fellows: 14

The Class of 2022-23 includes a Nobel Prize recipient and multiple National Academies-level scholars, plus a distinguished lecturer.

Source: tamu.edu
Iain Boyd – The Conversation - Vimarsana News

Iain Boyd – The Conversation

Iain Boyd’s profile on The Conversation

Biosimulation Market 2022 Size, Analysis, Top Players and Future Forecasts to 2028 | In Silico Biosc - Vimarsana News

Biosimulation Market 2022 Size, Analysis, Top Players and Future Forecasts to 2028 | In Silico Biosc

The first class Biosimulation market report works upon a number of industry and market parameters including latest trends, market segmentation, new market entry, industry forecasting, target market analysis, future directions, opportunity identification, strategic analysis, insights and innovation. An explicit marke...

Frontiers | Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2 - Vimarsana News

Frontiers | Molecular Docking and Dynamics Studies to Explore Effective Inhibitory Peptides Against the Spike Receptor Binding Domain of SARS-CoV-2

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic due to the high transmission and mortality rate of this virus. The world health and economic sectors have been severely affected by this deadly virus, exacerbated by the lack of sufficient efficient vaccines. The design of effective drug candidates and their rapid development is necessary to combat this virus. In this study, we selected 23 antimicrobial peptides from the literature and predicted their structure using PEP-FOLD 3.5. In addition, we docked them to the SARS-CoV-2 spike protein receptor...